Additive manufacturing in drug delivery: Innovative drug product design and opportunities for industrial application

被引:41
作者
Ragelle, Heloise [1 ]
Rahimian, Sima [2 ]
Guzzi, Elia A. [3 ]
Westenskow, Peter D. [1 ]
Tibbitt, Mark W. [3 ]
Schwach, Gregoire [2 ]
Langer, Robert [4 ,5 ]
机构
[1] F Hoffmann La Roche Ltd, Roche Innovat Ctr Basel, Roche Pharma Res & Early Dev, CH-4070 Basel, Switzerland
[2] F Hoffmann La Roche Ltd, Tech Dev Europe Biol, Pharmaceut Dev, CH-4070 Basel, Switzerland
[3] Swiss Fed Inst Technol, Dept Mech & Proc Engn, Macromol Engn Lab, CH-8092 Zurich, Switzerland
[4] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA
[5] MIT, Dept Chem Engn, Cambridge, MA 02142 USA
关键词
Additive manufacturing; Drug delivery systems; 3D printing; ARTIFICIAL NEURAL-NETWORKS; DEPOSITION MODELING FDM; POSTERIOR SEGMENT; MEDICAL DEVICES; RELEASE; THERAPY; MICROPARTICLES; OPTIMIZATION; TECHNOLOGIES; MICROSPHERES;
D O I
10.1016/j.addr.2021.113990
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Additive manufacturing (AM) or 3D printing is enabling new directions in product design. The adoption of AM in various industrial sectors has led to major transformations. Similarly, AM presents new opportunities in the field of drug delivery, opening new avenues for improved patient care. In this review, we discuss AM as an innovative tool for drug product design. We provide a brief overview of the different AM processes and their respective impact on the design of drug delivery systems. We highlight several enabling features of AM, including unconventional release, customization, and miniaturization, and discuss several applications of AM for the fabrication of drug products. This includes products that have been approved or are in development. As the field matures, there are also several new challenges to broad implementation in the pharmaceutical landscape. We discuss several of these from the regulatory and industrial perspectives and provide an outlook for how these issues may be addressed. The introduction of AM into the field of drug delivery is an enabling technology and many new drug products can be created through productive collaboration of engineers, materials scientists, pharmaceutical scientists, and industrial partners. (c) 2021 Published by Elsevier B.V.
引用
收藏
页数:21
相关论文
共 191 条
[1]   Overcoming Challenges Facing Advanced Therapies in the EU Market [J].
Abou-El-Enein, Mohamed ;
Elsanhoury, Ahmed ;
Reinke, Petra .
CELL STEM CELL, 2016, 19 (03) :293-297
[2]   ARTIFICIAL NEURAL NETWORKS - IMPLICATIONS FOR PHARMACEUTICAL SCIENCES [J].
ACHANTA, AS ;
KOWALSKI, JG ;
RHODES, CT .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1995, 21 (01) :119-155
[3]   Engineering precision biomaterials for personalized medicine [J].
Aguado, Brian A. ;
Grim, Joseph C. ;
Rosales, Adrianne M. ;
Watson-Capps, Jana J. ;
Anseth, Kristi S. .
SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (424)
[4]   Micro and nanoscale technologies in oral drug delivery [J].
Ahadian, Samad ;
Finbloom, Joel A. ;
Mofidfar, Mohammad ;
Diltemiz, Sibel Emir ;
Nasrollahi, Fatemeh ;
Davoodi, Elham ;
Hosseini, Vahid ;
Mylonaki, Ioanna ;
Sangabathuni, Sivakoti ;
Montazerian, Hossein ;
Fetah, Kirsten ;
Nasiri, Rohollah ;
Dokmeci, Mehmet Remzi ;
Stevens, Molly M. ;
Desai, Tejal A. ;
Khademhosseini, Ali .
ADVANCED DRUG DELIVERY REVIEWS, 2020, 157 :37-62
[5]  
Ali K.P., Patent No. [10926005B2, 10926005]
[6]   Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum [J].
Alkilani, Ahlam Zaid ;
McCrudden, Maeliosa T. C. ;
Donnelly, Ryan F. .
PHARMACEUTICS, 2015, 7 (04) :438-470
[7]   Self-Adhesive Microneedles with Interlocking Features for Sustained Ocular Drug Delivery [J].
Amer, Maher ;
Chen, Roland K. .
MACROMOLECULAR BIOSCIENCE, 2020, 20 (06)
[8]   Characterization and Pharmacological Evaluation of Anti-Cellulite Herbal Product(s) Encapsulated in 3D-Fabricated Polymeric Microneedles [J].
Amer, Reham, I ;
El-Osaily, Ghada H. ;
Bakr, Riham O. ;
El Dine, Riham Salah ;
Fayez, Ahmed M. .
SCIENTIFIC REPORTS, 2020, 10 (01)
[9]  
[Anonymous], AR 1105 IMPL
[10]  
[Anonymous], 2021, PHARM DRUG DELIVERY